USCCC Resources & References
Item Details Page

If details were added to our index, you can view them here, or you can view the source. 

Washington Post

GlaxoSmithKline Executive Prevented from Leaving China

Article/ Pub

Visas / Residency / Work Permits

July 17, 2013

By Katerina Sokou

China has stepped up its anti-corruption campaign against GlaxoSmithKline, blocking a senior executive of one of the world’s largest pharmaceutical companies from leaving the country...

Preventing a foreign executive from leaving the country is bound to create a stir among Western companies, some analysts said.

“Whether it is going to create a problem for the expatriates who live in China, certainly it will have a negative impact, but I do not think it will be dramatic,” said Siva Yam, president of the United States of America-China Chamber of Commerce.

But he noted: “It does not matter if they are foreign or Chinese, if they have committed a crime based on the local law then they have a problem.”